FDA Approves ANNOVERA — Mayne Pharma

Mayne Pharma has announced the FDA approval of ANNOVERA (segesterone acetate and ethinyl estradiol) vaginal ring, setting the stage to disrupt the contraceptive market. This long-acting product challenges existing market leaders by offering a device-based alternative with an extended duration of行动 and high efficacy.